Human intestinal epithelial and smooth muscle cells are potent producers of IL‐6
Open Access
- 1 January 2003
- journal article
- Published by Wiley in Mediators of Inflammation
- Vol. 12 (1) , 3-8
- https://doi.org/10.1080/0962935031000096917
Abstract
Background: Interleukin‐6 (IL‐6), a pluripotent cytokine, has traditionally been considered the product of proinflammatory cells. However, many other cell types have been shown to produce IL‐6. Since intestinal inflammation is commonly associated with a vigorous systemic inflammatory response, we hypothesized that intestinal epithelial and smooth muscle cells might contribute to that response by producing IL‐6. We therefore studied the capacity of differentiated human intestinal epithelial and smooth muscle cell lines to produce IL‐6 in response to various proinflammatory stimuli.Materials and methods: CCL‐241, a human intestinal epithelial cell line, and HISM, a human intestinal muscle cell line, were grown to confluency and then treated for 24 h with various concentrations of lipopolysaccharide,Clostridium difficile culture extract containing both toxin A and toxin B, recombinant human tumor necrosis factor‐alpha (TNF‐α), or recombinant human interleukin‐1 beta (IL‐1β). Supernatants were then collected for IL‐6 determination using an enzyme‐linked immunosorbent assay. Cell numbers were determined using a Coulter counter. For comparison, parallel studies were performed using phorbol ester‐primed U‐937 and THP‐1 human macrophage cell lines.Results: Both human intestinal epithelial and smooth muscle cells produced IL‐6 under basal conditions. In HISM cells, but not in CCL‐241 cells, IL‐6 release was increased slightly by treatment with C. difficile culture extract containing both toxin A and toxin B and with lipopolysaccharide. In both cell lines, IL‐6 production was profoundly stimulated by treatment with IL‐1β and less so with TNF‐α. Combinations of high‐dose TNF‐α and IL‐1β may have a slightly additive, but not synergistic, effect on IL‐6 release. The amount of IL‐6 produced by IL‐1‐stimulated intestinal cell lines was 70‐fold higher than that produced by stimulated macrophage cell lines.Conclusions: Both intestinal epithelial and smooth muscle cells demonstrate the ability to release significant amounts of IL‐6. The profound response to IL‐1β and TNF‐α stimulation by both cell lines suggests that human intestinal parenchymal cells, influenced by paracrine mediators liberated from proinflammatory cells, might significantly contribute to the overall systemic inflammatory response by producing IL‐6.Keywords
Funding Information
- Surgical Infection Society
This publication has 49 references indexed in Scilit:
- C5a Receptor and Interleukin-6 Are Expressed in Tissue Macrophages and Stimulated Keratinocytes but not in Pulmonary and Intestinal Epithelial CellsThe American Journal of Pathology, 1999
- Lipopolysaccharide- and Proinflammatory Cytokine-Induced Energy Production in Intestinal and Colonic Epithelial Cell LinesScandinavian Journal of Gastroenterology, 1999
- Elevated cell‐associated levels of interleukin 1β and interleukin 6 in inflamed mucosa of inflammatory bowel diseaseEuropean Journal of Clinical Investigation, 1996
- Interleukin 1β induces the expression of interleukin 6 in rat intestinal smooth muscle cellsGastroenterology, 1995
- Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependentDigestive Diseases and Sciences, 1995
- Serum Interleukin-6 Is Related to Disease Activity but Not Disease Specificity in Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology, 1995
- Mucosal Interleukin-6 Secretion in Ulcerative Colitis: Effects of Anti-Inflammatory Drugs and T-Cell StimulationScandinavian Journal of Gastroenterology, 1994
- Expression of interleukin-6 by intestinal enterocytes.Journal of Clinical Pathology, 1993
- Biological and clinical aspects of interleukin 6Immunology Today, 1990
- Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts.The Journal of Experimental Medicine, 1987